logologo
QuantliQuantli

Ocugen Inc

OCGN

NASDAQ

Biotechnology

$1.35

USD

0.00 (0.00%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $457.80M

Volume 3.0M

Price Target

$11.00$11.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $11.00 and a min estimate of $11.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$11.00

+$1.3 vs prior

Implied Upside

+714.8%

+92.6% vs prior

Analyst Covering

1

-3 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

20%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Whitney Ijem

Canaccord Genuity

Buy

Maintained

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

CABA

Cabaletta Bio Inc

$2.75

+1.5%

CCCC

C4 Therapeutics, Inc

$4.24

+3.9%

QTTB

Q32 Bio Inc

$15.15

-1.4%

KYTX

Kyverna Therapeutics Inc

$8.17

+1.1%

OVID

Ovid Therapeutics Inc

$2.83

+1.1%

LRMR

Larimar Therapeutics Inc

$4.36

+2.1%

PBYI

Puma Biotechnology Inc

$8.83

+1.4%

MPLT

MapLight Therapeutics Inc

$11.75

+1.5%